pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
VIATRIS · news · pharmadog
← back to VIATRIS
News mentioning VIATRIS
13
stories
22h
As part of sales reorganization, Novo will cut 215 employees at US HQ
biospace
29d
Roche bets up to $813M on Zymeworks’ lung cancer trispecific T cell engager
biospace
Oct 9, 26
Viatris inks $1.65B Pacira buyout to build non-opioid pain therapy business
biospace
Oct 8, 26
Viatris to make $1.65B Pacira acquisition, adding to momentum in pain
endpoints
Oct 8, 26
Viatris boosts pain drug portfolio with $1.7B buyout of Pacira
biopharma dive
Oct 8, 26
STAT+: Roche goes beyond licensing in deal with Chinese biotech
stat
Jul 24, 26
Merck stages expanded access to monthly HIV PrEP pill ahead of approval
fiercebiotech
Jul 23, 26
Biopharma layoffs must double in H2 for 2026 to match 2025 cuts
biospace
Jul 22, 26
Webinar: From Clinical to Commercial: Talent Strategies for Biopharma Growth
biospace
Jul 22, 26
FDA issues untitled letters to Sanofi and Viatris for false advertising
raps
Jul 16, 26
Spurred by deep cuts and M&A activity, H1 layoffs could oust 14,000+ in biopharma
biospace
Jun 29, 26
Theravance, after clinical setbacks, agrees to $929M buyout
biopharma dive
Dec 23, 25
Fierce Biotech Layoff Tracker 2026: Milestone shrinks HQ workforce during Cardamyst rollout
fiercebiotech